A New Strategy to Transform Liver Cancer Immunotherapy
UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.
UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.
UC San Diego School of Medicine partners with The Michael J. Fox Foundation on a clinical study to identify biomarkers of Parkinson’s disease. The study seeks to recruit 4,000 participants by the end of 2023.
Researchers report that an abbreviated, seven-item scale can help determine with high validity a person’s level of wisdom, a potentially modifiable personality trait that has been shown to have a strong association to well-being.
Scott Lippman, MD, will lead the PreCancer Genome Atlas, an NCI-sponsored effort to map premalignant lesions and how they evolve into invasive cancers.
Novel randomized controlled trial found that families with high consumption of avocados experienced reduced caloric intake and an overall healthier diet, without actually changing their diet.
Researchers reveal a previously unrealized complexity in cancer development, one that raises concerns and caution about targeting an enzyme popular in oncological treatments.
Forbes, May 29
San Diego Union Tribune, May 28
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.